SARS-CoV-2 Transmission in Patients With Cancer at a Tertiary Care Hospital in Wuhan, China

Jing Yu; Wen Ouyang; Melvin L K Chua; Conghua Xie

doi:10.1001/jamaoncol.2020.0980

SARS-CoV-2 Transmission in Patients With Cancer at a Tertiary Care Hospital in Wuhan, China

JAMA Oncol. 2020 Jul 1;6(7):1108-1110. doi: 10.1001/jamaoncol.2020.0980.

Authors

Jing Yu^{1

2

3}, Wen Ouyang^{1

2

3}, Melvin L K Chua^{1

4

5}, Conghua Xie^{1

2

3}

Affiliations

¹ Department of Radiation and Medical Oncology, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, People's Republic of China.
² Hubei Key Laboratory of Tumor Biological Behaviors, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, People's Republic of China.
³ Hubei Cancer Clinical Study Center, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, People's Republic of China.
⁴ Division of Radiation Oncology, Division of Medical Sciences, National Cancer Centre Singapore, Singapore.
⁵ Oncology Academic Programme, Duke-NUS Medical School, Singapore.

Abstract

This cross-sectional study reviews the medical records of 1524 patients with cancer treated at a single tertiary care hospital in Wuhan, China, to evaluate the characteristics associated with transmission of the SARS-CoV-2 virus.

MeSH terms

Betacoronavirus / pathogenicity*
COVID-19
China / epidemiology
Coronavirus Infections / complications
Coronavirus Infections / epidemiology
Coronavirus Infections / transmission*
Coronavirus Infections / virology
Female
Humans
Male
Medical Records
Middle Aged
Neoplasms / complications
Neoplasms / epidemiology*
Neoplasms / pathology
Neoplasms / virology
Pandemics
Pneumonia, Viral / complications
Pneumonia, Viral / epidemiology
Pneumonia, Viral / transmission*
Pneumonia, Viral / virology
Risk Factors
SARS-CoV-2
Tertiary Care Centers